Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biolinerx Ltd ADR (NQ: BLRX )

0.6233 +0.0035 (+0.56%)
Streaming Delayed Price Updated: 3:57 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 74,325
Open 0.6100
Bid (Size) 0.6205 (1)
Ask (Size) 0.6260 (1)
Prev. Close 0.6198
Today's Range 0.6100 - 0.6450
52wk Range 0.5100 - 2.300
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BLRX Stock Earnings: BioLine Rx Beats Revenue for Q2 2024
BLRX stock results show that BioLine Rx beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday morning! 
Via InvestorPlace

Performance

YTD
-59.26%
-59.26%
1 Month
-21.10%
-21.10%
3 Month
+1.15%
+1.15%
6 Month
-47.18%
-47.18%
1 Year
-68.99%
-68.99%

More News

Read More
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
Via InvestorPlace
BLRX Stock Earnings: BioLine Rx Beats EPS for Q1 2024
Via InvestorPlace
BLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023
Via InvestorPlace
Earnings Preview For BioLine Rx
Via Benzinga
BioLine Rx Earnings Preview
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for BioLine Rx: Here's What You Need To Know
Via Benzinga
BioLineRx Ltd. (NASDAQ: BLRX) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 26, 2024
Via Benzinga
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth
Via FinancialNewsMedia
A Preview Of BioLine Rx's Earnings
Via Benzinga
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond
Via InvestorPlace
Earnings Scheduled For November 20, 2023
Via Benzinga
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
Via Talk Markets
3 Tech Stocks That Wall Street Loves More Than Nvidia
Via InvestorPlace
3 Top Penny Stocks to Make You a Millionaire in 5 Years
Via InvestorPlace
BioLineRx Touts Encouraging Data From Therapy Trial For First Line Pancreatic Cancer
Via Benzinga
Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Earnings Scheduled For August 30, 2023
Via Benzinga
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
Via InvestorPlace
3 Smart Penny Stocks with Huge Potential
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
Via InvestorPlace
Earnings Scheduled For May 24, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.